FairScope Lab
EN 繁中 简中

BIIB

Valuation Healthcare · Drug Manufacturers - General Data as of 2025-12-31

P/E Ratio · Metrics

P/E Ratio

-

PEG Ratio

-

Dividend Yield

-

Gross Margin

78.23%

Net Margin

-2.12%

Revenue CAGR 3Y

-3.60%

ROE

-1.06%

ROA

-0.66%

Buyback Yield

0.27%

Current Ratio

2.68

Magic Earn Yield

-0.77%

Altman Z-Score

2.66

Fair Value River

Score

Valuation 0
Profitability 20
Growth 0
Health 71
Yield 5
← Back to Dashboard